Skip Navigation


NDT Advance Access originally published online on December 22, 2004
Nephrology Dialysis Transplantation 2005 20(2):349-353; doi:10.1093/ndt/gfh650
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/2/349    most recent
gfh650v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dussol, B.
Right arrow Articles by Berland, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dussol, B.
Right arrow Articles by Berland, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant Vol. 20 No. 2 © ERA–EDTA 2004; all rights reserved


Original Article

A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension

Bertrand Dussol1,2, Julie Moussi-Frances1, Sophie Morange2, Claude Somma-Delpero3, Olivier Mundler3 and Yvon Berland1,2

1 Service de Néphrologie-Hémodialyse-Transplantation, Hôpital de la Conception, 2 Centre d’Investigation Clinique, Hôpital Sainte Marguerite and 3 Service de Médecine Nucléaire, Hôpital de la Timone, Marseille, France

Correspondence and offprint requests to: Professeur Bertrand Dussol, Service de Néphrologie-Hémodialyse-Transplantation, Hôpital de la Conception, 147 Bd Baille, 13385 Marseille Cedex 5, France. Email: bdussol{at}mail.ap-hm.fr

Background. Loop diuretics are the drugs of choice for the treatment of hypertension in chronic renal failure patients. However, the adaptive changes in the distal nephron and the short half-life of these drugs may decrease their long-term efficacy. Thiazides are not believed to be efficient in advanced renal failure, but this is debated.

Methods. We compared the efficacy of long-acting furosemide (60 mg/day) and hydrochlorothiazide (25 mg/day) in a double-blind, randomized crossover trial in seven patients with severe renal failure and hypertension (seven men, 54±10 years old). The primary end-points were sodium and chloride fractional excretions after 1 month of each diuretic and then after their combination. During the trial, other treatments and the diet were controlled.

Results. A trend towards an increase in the fractional excretion of sodium and of chloride was observed with furosemide, but the difference did not reach the level of statistical significance (P = NS). Hydrochlorothiazide significantly increased fractional excretion of sodium and chloride from 3.7±0.9 to 5.5±0.3 and from 3.9±0.19 to 6.5±0.3, respectively (P<0.05). The combination of the two diuretics had no additional effect on the increase in sodium and chloride fractional excretion. Furosemide, hydrochlorothiazide and the combination of the two diuretics decreased mean arterial blood pressure by the same extent from 112 to 97, 99 and 97 mmHg, respectively (P<0.05).

Conclusions. Hydrochlorothiazide increased the fractional excretion of sodium and chloride more than furosemide did in hypertensive severe renal failure patients. Mean arterial blood pressure decreased by the same amount with both diuretics. Combining furosemide and hydrochlorothiazide did not increase the efficacy of hydrochlorothiazide.

Keywords: fractional excretion; furosemide; hydrochlorothiazide; hypertension; renal failure; sodium


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
C. K. Fujihara, D. M. A. C. Malheiros, and R. Zatz
Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1810 - F1818.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.